Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant.
Burns DM, Clesham K, Hodgson YA, Fredrick L, Haughton J, Lannon M, Hussein H, Shin JS, Hollows RJ, Robinson L, Byrne C, McNamara C, Vydianath B, Lennard AL, Fields P, Johnson R, Wright J, Fox CP, Cwynarski K, Chaganti S.
Burns DM, et al. Among authors: lannon m.
Transplantation. 2020 Dec;104(12):2582-2590. doi: 10.1097/TP.0000000000003183.
Transplantation. 2020.
PMID: 33104308